RPG Life Sciences vs Peers
- Market cap
- ₹4,487 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,953.14 – ₹3,662.14
RPG Life Sciences ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are RPG Life Sciences. Its P/E of 22.5 compares with a peer median of 22.5.
RPG Life Sciences vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| RPG Life Sciences | 2,712.70 | -6.23% | 4,487 | 22.5 | 2.85 | 14.5% | +18.5% |
| RPG Life Sciences | 2,712.70 | -6.23% | 4,487 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
RPG Life Sciences peer comparison — frequently asked questions
Who are RPG Life Sciences' competitors?
RPG Life Sciences' listed peers in Drug Manufacturers - Specialty & Generic include RPG Life Sciences, ranked here by market capitalisation.
How does RPG Life Sciences' P/E compare with its peers?
RPG Life Sciences trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among RPG Life Sciences' peers?
By market capitalisation, the largest company in the group is RPG Life Sciences at ₹4,487 crore, against ₹4,487 crore for RPG Life Sciences.
Same Data For Peers
Trade RPG Life Sciences With ATS
Track RPGLIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.